OmniAb Inc

NASDAQ:OABI  
4.17
-0.17 (-3.92%)
7:17:00 PM EDT: $4.25 +0.08 (+1.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)460.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$25.72 Million
Adjusted EPS$0.02
See more estimates
10-Day MA$4.19
50-Day MA$3.67
200-Day MAN/A
See more pivots

OmniAb Inc Stock, NASDAQ:OABI

5980 Horton Street, Suite 600, Emeryville, California 94608
United States of America
Phone: +1.510.250.7800
Number of Employees:

Description

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. The firm�s platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.